文档下载 文档下载导航
设为首页 | 加入收藏
搜索 请输入内容:  
 导航当前位置: 文档下载 > 所有分类 > 医药卫生 > 基因多态性Statin myotoxicity A review of genetic susceptibility factors
侵权投诉

基因多态性Statin myotoxicity A review of genetic susceptibility factors

Availableonlineatdoc.guandang.net

ScienceDirect

NeuromuscularDisorders24(2014)

基因多态性Statin myotoxicity A review of genetic susceptibility factors

基因多态性Statin myotoxicity A review of genetic susceptibility factors

基因多态性Statin myotoxicity A review of genetic susceptibility factors

基因多态性Statin myotoxicity A review of genetic susceptibility factors

基因多态性Statin myotoxicity A review of genetic susceptibility factors

4–15

doc.guandang.net

Review

Statinmyotoxicity:Areviewofgeneticsusceptibilityfactors

M.Needham ,F.L.Mastaglia

AustralianNeuromuscularResearchInstitute,CentreforNeuromuscular&NeurologicalDisorders,UniversityofWesternAustralia,Australia

Received5June2013;receivedinrevisedform8September2013;accepted20September2013

Abstract

The3-hydroxy-3-methylglutarylcoenzymeA(HMGCoA)reductaseinhibitors(statins)areamongthemostcommonmedicationsprescribedworldwide,buttheire cacyandtoxicityvarybetweenindividuals.Oneofthemajorfactorscontributingtointoleranceandnon-compliancearethemuscleside-e ects,whichrangefrommildmyalgiathroughtoseverelife-threateningrhabdomyolysis.Onewaytoaddressthisispharmacogenomicscreening,whichaimstoindividualizetherapytomaximizee cacywhilstavoidingtoxicity.Genesencodingproteinsinvolvedinthemetabolismofstatinsaswellasgenesknowntocauseinheritedmuscledisordershavebeeninvestigated.To-dateonlypolymorphismsintheSLCO1B1gene,whichencodestheproteinresponsibleforhepaticuptakeofstatins,andtheCOQ2gene,importantinthesynthesisofcoenzymeQ10,havebeenvalidatedasbeingstronglyassociatedwithstatin-inducedmyopathy.Theaimofthisreviewistosummarizestudiesinvestigatinggeneticfactorspredisposingtostatinmyopathyandmyalgia,asthe rststeptowardspharmacogenomicscreeningtoidentifyatriskindividuals.Ó2013ElsevierB.V.Allrightsreserved.

Keywords:3-Hydroxy-3-methylglutarylcoenzymeA(HMGCoA)reductaseinhibitors;Statins;Pharmacogenomics;Genetics;Myopathy;Myalgia;Muscle

1.Introduction

The3-Hydroxy-3-methylglutarylcoenzymeA(HMGCoA)reductaseinhibitors(statins)arethemostpotentdrugsavailabletotreathypercholesterolaemia,whichisimplicatedinthepathogenesisofcoronaryarterydisease,cerebrovasculardiseaseandperipheralvasculardisease.StatinsareamongthemostwidelyprescribeddrugsintheUSA[1],andareusedbyanestimated38millionpeopleintheUSA[2].However,theire ectivenesshasbeenunderminedbytheiradversee ects,particularlyonskeletalmuscle.ThiswashighlightedwiththewithdrawalofCerivastatinin2001becauseofanincreasedfrequencyofsevererhabdomyolysisanddeath.Adversemusclereactionsare

Correspondingauthor.Address:AustralianNeuromuscularResearch

Institute,Level4,ABlock,QEIIMedicalCentre,Nedlands,WesternAustralia6009,Australia.Tel.:+61893463980;fax:+61893461245.E-mailaddress:Merrilee.needham@health.wa.gov.au(M.Needham).0960-8966/$-seefrontmatterÓ2013ElsevierB.V.Allrightsreserved.doc.guandang.net

oneofthemostcommonreasonsfornon-compliancewithstatintherapy[3,4],andtheycanhaveasigni cantimpactonqualityoflife[5].ThemyotoxicityofstatinscanbemildsuchasasymptomatichyperCKaemia[6],andincreasinginseveritythroughaspectrumofmyalgiawithouthyperCKaemia,proximalweaknesswithhyperCKaemia,necrotizingautoimmunemyositis(NAM),tosevereandattimesfatalrhabdomyolysis.

Thetrueincidenceofstatinmyopathyisstilluncertain,andisdependentonvariousfactorsincludingthede nitionusedforstatinmyopathy,thedoseandtypeofstatin,presenceofotherco-medications[7]andlevelsofphysicalexercise[8].Whilstclinicaltrialdatasuggestedtheincidenceofmusclesymptomswassimilartoplacebo[9–11],somesubsequentlargecommunity-basedstudieshavefoundanincidenceofmildmusclesymptomsashighas10–20%[12–14].Howevermoststudieshaveagreedthattheriskofseveremusclee ectssuchasrhabdomyolysisisverylow(0.003–0.1%)[7,12,15–19].Oneofthemajorproblemsininterpretingandcomparing

第1页

TOP相关主题

你可能喜欢

热门文档

站点地图 | 文档上传 | 侵权投诉 | 手机版
本站所有资源均来自互联网,本站只负责收集和整理,均不承担任何法律责任,如有侵权等其它行为请联系我们.
文档下载 Copyright 2013 doc.guandang.net All Rights Reserved.  -  email